The Immune Tolerance Network (ITN), led by Benaroya Research Institute (BRI), has made major breakthroughs in fighting peanut allergies.
BRI scientists have learned there are multitudes of different immune system cell types, and few are exactly alike.
BRI is relatively small compared to large research universities, but its impact goes well beyond its size and location through key collaborations with numerous external investigators.
Over the last few years, several unique and pioneering technologies at BRI have been combined to create a “pipeline” approach to find and study rare disease-associated cells.
© 2022 Benaroya Research Institute at Virginia Mason. 1201 Ninth Avenue, Seattle, WA 98101-2795